In Vivo | Growth Anticipated For RNA Therapies In New Indications
DTx Pharma featured in In Vivo Informa Pharma Intelligence. September 1, 2021. Scroll down to read more.
DTx Pharma featured in In Vivo Informa Pharma Intelligence. September 1, 2021. Scroll down to read more.
SAN DIEGO--(BUSINESS WIRE)--DTx Pharma, Inc. (DTx), a privately-held biotechnology company creating novel RNA-based therapeutics to treat the genetic drivers of disease, today announced that [...]
San Diego – October 5, 2021 – DTx Pharma, Inc. (DTx), a privately-held biotechnology company creating novel RNA-based therapeutics to treat the genetic drivers of [...]